Mary Crowley Cancer Research Centers’ mission is to expand treatment options for all cancer patients through investigational vaccine, gene and cellular therapies.
The Mary Crowley Cancer Research Centers offers multiple advanced research options to patients with many forms of cancer.
Through a personalized approach, Mary Crowley patients receive a customized plan as unique as each individual. This patient-centric model allows the physicians to take the most promising laboratory discoveries and tailor options to the patient’s genetic profile.
The FDA in its critical mission to advance the safety of medical care has had the opportunity to review and pass judgment on the evidence and science of the planned study.
The early phase clinical trials offered at Mary Crowley are more specialized, less toxic, and exquisitely designed to target key molecular pathways that impact cancer growth, while minimizing harm to the body’s healthy cells.
Highly trained personnel provide support for Phase I and Phase II clinical trial protocols, using innovative technologies and meeting FDA guidelines.
The purpose of these trials is to characterize the mechanism of action, activity and safety of gene and cellular therapies.
For more information about Mary Crowley Cancer Research Centers, please visit www.marycrowley.org.
For more information about our Comprehensive Breast Center, talk with your doctor or call 561-650-6023 or toll free 1-877-725-0444 for a free physician referral.